Research has observed a decreased risk of autoimmune disorders, including MS, in people who consume alcohol. However, it is not known whether patients may reduce their alcohol consumption as their disease progresses.
In a recent study, the investigational drug, PIPE-307, effectively induced OPC differentiation and remyelination in MS donor human brain tissue and an animal model and restored lost function in an MS mouse model.
New research published in Nature Scientific Reports revealed that people with MS are more prone to experience a short-term reduction in disability and brain lesion volume after receiving stem cell therapy.